Investors Pick Up ITCI 16.2% Lower Than Its Secondary Stock Offering
December 14, 2020 at 09:59 AM EST
Looking back to 95 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 11,666,667 share secondary stock offering at $30.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..